Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoclasts | 23 | 2021 | 469 | 3.800 |
Why?
|
| Bone Resorption | 12 | 2020 | 326 | 2.440 |
Why?
|
| Osteogenesis | 7 | 2020 | 377 | 2.070 |
Why?
|
| Aging | 6 | 2021 | 784 | 2.070 |
Why?
|
| RANK Ligand | 13 | 2020 | 183 | 1.610 |
Why?
|
| Osteoporosis | 3 | 2021 | 164 | 1.390 |
Why?
|
| Bone and Bones | 9 | 2020 | 516 | 1.300 |
Why?
|
| Mitochondria | 3 | 2021 | 489 | 1.250 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2012 | 56 | 1.160 |
Why?
|
| Osteoblasts | 10 | 2021 | 514 | 1.120 |
Why?
|
| Estrogens | 4 | 2021 | 244 | 1.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 7 | 2013 | 65 | 1.020 |
Why?
|
| Forkhead Transcription Factors | 4 | 2017 | 118 | 0.880 |
Why?
|
| Mice | 28 | 2021 | 6413 | 0.850 |
Why?
|
| Benzamides | 2 | 2012 | 54 | 0.830 |
Why?
|
| Cell Differentiation | 13 | 2020 | 720 | 0.820 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 242 | 0.810 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 17 | 0.800 |
Why?
|
| Pyridines | 2 | 2012 | 137 | 0.760 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 8 | 0.760 |
Why?
|
| Bone Density | 3 | 2020 | 416 | 0.750 |
Why?
|
| Stem Cells | 3 | 2019 | 193 | 0.750 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 57 | 0.740 |
Why?
|
| Animals | 31 | 2021 | 14385 | 0.690 |
Why?
|
| Sirtuin 1 | 2 | 2015 | 29 | 0.660 |
Why?
|
| Osteocytes | 1 | 2020 | 220 | 0.620 |
Why?
|
| Signal Transduction | 9 | 2020 | 1753 | 0.530 |
Why?
|
| Mice, Knockout | 4 | 2021 | 926 | 0.510 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 418 | 0.480 |
Why?
|
| Bone Marrow Cells | 10 | 2015 | 233 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 1999 | 0.440 |
Why?
|
| Down-Regulation | 3 | 2012 | 388 | 0.420 |
Why?
|
| NFATC Transcription Factors | 5 | 2013 | 20 | 0.410 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 35 | 0.400 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 99 | 0.390 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 47 | 0.350 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1062 | 0.340 |
Why?
|
| NF-kappa B | 3 | 2017 | 335 | 0.320 |
Why?
|
| Cells, Cultured | 9 | 2020 | 1737 | 0.320 |
Why?
|
| Mice, Inbred ICR | 6 | 2013 | 25 | 0.290 |
Why?
|
| Coculture Techniques | 6 | 2013 | 160 | 0.280 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 656 | 0.280 |
Why?
|
| Estrogen Receptor alpha | 3 | 2016 | 95 | 0.270 |
Why?
|
| Bone Neoplasms | 3 | 2012 | 193 | 0.250 |
Why?
|
| Interleukin-1 | 4 | 2013 | 107 | 0.240 |
Why?
|
| Female | 12 | 2021 | 28441 | 0.230 |
Why?
|
| Chemokine CXCL12 | 2 | 2020 | 31 | 0.220 |
Why?
|
| Cell Count | 2 | 2020 | 181 | 0.220 |
Why?
|
| Male | 14 | 2021 | 27334 | 0.210 |
Why?
|
| Bone Remodeling | 3 | 2020 | 177 | 0.200 |
Why?
|
| Cell Lineage | 3 | 2016 | 93 | 0.200 |
Why?
|
| Porosity | 2 | 2017 | 34 | 0.190 |
Why?
|
| Osteolysis | 2 | 2012 | 88 | 0.190 |
Why?
|
| Chemokine CXCL10 | 2 | 2012 | 20 | 0.190 |
Why?
|
| Adipogenesis | 1 | 2020 | 52 | 0.190 |
Why?
|
| Phospholipids | 1 | 2020 | 63 | 0.190 |
Why?
|
| Dinoprostone | 3 | 2009 | 55 | 0.170 |
Why?
|
| Osteoprotegerin | 4 | 2013 | 57 | 0.160 |
Why?
|
| Phenanthrenes | 2 | 2008 | 13 | 0.160 |
Why?
|
| GATA4 Transcription Factor | 1 | 2017 | 13 | 0.150 |
Why?
|
| Sulfonamides | 2 | 2017 | 146 | 0.150 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 21 | 0.150 |
Why?
|
| Hydrogen Peroxide | 2 | 2016 | 142 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 65 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2017 | 98 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2017 | 66 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 93 | 0.150 |
Why?
|
| Enzyme Activation | 2 | 2015 | 329 | 0.150 |
Why?
|
| Aniline Compounds | 1 | 2017 | 48 | 0.150 |
Why?
|
| Base Sequence | 3 | 2014 | 719 | 0.140 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 42 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 21 | 0.140 |
Why?
|
| Apoptosis | 2 | 2020 | 1300 | 0.130 |
Why?
|
| Acetylation | 1 | 2015 | 99 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 49 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 250 | 0.130 |
Why?
|
| Androgens | 1 | 2015 | 68 | 0.130 |
Why?
|
| Antioxidants | 2 | 2009 | 297 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 357 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 169 | 0.130 |
Why?
|
| Histones | 1 | 2017 | 335 | 0.120 |
Why?
|
| Catalase | 1 | 2014 | 74 | 0.120 |
Why?
|
| Bone Development | 1 | 2014 | 69 | 0.120 |
Why?
|
| Trapidil | 1 | 2013 | 1 | 0.120 |
Why?
|
| beta Catenin | 1 | 2014 | 102 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 980 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 206 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 1 | 2013 | 83 | 0.110 |
Why?
|
| Ovariectomy | 3 | 2020 | 125 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2013 | 203 | 0.110 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2012 | 39 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2012 | 389 | 0.110 |
Why?
|
| Janus Kinase 2 | 2 | 2008 | 31 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 491 | 0.100 |
Why?
|
| Response Elements | 1 | 2011 | 32 | 0.100 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 180 | 0.100 |
Why?
|
| Cell Line | 2 | 2012 | 1153 | 0.100 |
Why?
|
| Models, Biological | 1 | 2015 | 823 | 0.100 |
Why?
|
| Lipopolysaccharides | 2 | 2009 | 199 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 125 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2020 | 293 | 0.100 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 47 | 0.100 |
Why?
|
| Bone Regeneration | 1 | 2011 | 71 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2011 | 177 | 0.100 |
Why?
|
| Mutation | 1 | 2017 | 1501 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 34 | 0.090 |
Why?
|
| Osteitis | 1 | 2009 | 1 | 0.090 |
Why?
|
| Vitamin E | 1 | 2011 | 107 | 0.090 |
Why?
|
| Catechin | 1 | 2009 | 30 | 0.090 |
Why?
|
| Skull | 1 | 2009 | 79 | 0.090 |
Why?
|
| Protein Binding | 1 | 2011 | 736 | 0.090 |
Why?
|
| Tyrphostins | 1 | 2008 | 16 | 0.090 |
Why?
|
| Macrophages | 2 | 2009 | 405 | 0.080 |
Why?
|
| Chromans | 1 | 2009 | 62 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 673 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 101 | 0.080 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2008 | 5 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 133 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 27 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2008 | 28 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 176 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1663 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 142 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 130 | 0.070 |
Why?
|
| Thioctic Acid | 1 | 2006 | 3 | 0.070 |
Why?
|
| X-Ray Microtomography | 2 | 2015 | 82 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3415 | 0.060 |
Why?
|
| DNA Primers | 2 | 2014 | 225 | 0.060 |
Why?
|
| Organ Size | 2 | 2015 | 237 | 0.060 |
Why?
|
| Femur | 2 | 2015 | 144 | 0.060 |
Why?
|
| Humans | 6 | 2017 | 54284 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 206 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1248 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 75 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 82 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 382 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 683 | 0.040 |
Why?
|
| Cell Survival | 2 | 2011 | 657 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 2 | 2008 | 49 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1198 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2016 | 37 | 0.040 |
Why?
|
| Models, Animal | 1 | 2017 | 255 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 368 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 1550 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 42 | 0.040 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2006 | 32 | 0.040 |
Why?
|
| Orchiectomy | 1 | 2015 | 38 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 45 | 0.030 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 269 | 0.030 |
Why?
|
| Gene Expression | 2 | 2008 | 664 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2006 | 359 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2013 | 1 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2014 | 110 | 0.030 |
Why?
|
| Atrophy | 1 | 2013 | 40 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2012 | 26 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2012 | 33 | 0.030 |
Why?
|
| Inflammation | 2 | 2008 | 674 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 635 | 0.030 |
Why?
|
| Exome | 1 | 2012 | 51 | 0.030 |
Why?
|
| Uterus | 1 | 2013 | 98 | 0.030 |
Why?
|
| Point Mutation | 1 | 2012 | 92 | 0.030 |
Why?
|
| Spine | 1 | 2013 | 111 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 820 | 0.030 |
Why?
|
| Estradiol | 1 | 2013 | 219 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 314 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 273 | 0.030 |
Why?
|
| Calcium | 1 | 2013 | 432 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 524 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 767 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 209 | 0.020 |
Why?
|
| Tocotrienols | 1 | 2011 | 42 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 52 | 0.020 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2010 | 24 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2010 | 38 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1096 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 219 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 283 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 137 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 158 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 252 | 0.020 |
Why?
|
| bcl-Associated Death Protein | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2008 | 41 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2008 | 11 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 96 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2008 | 46 | 0.020 |
Why?
|
| Flagellin | 1 | 2008 | 4 | 0.020 |
Why?
|
| Caspases | 1 | 2008 | 146 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 84 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 169 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2008 | 43 | 0.020 |
Why?
|
| Bone Diseases | 1 | 2008 | 109 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 958 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 216 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 273 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2006 | 10 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 134 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2006 | 44 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 866 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 1639 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6897 | 0.010 |
Why?
|
| Child | 1 | 2012 | 7341 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 14207 | 0.010 |
Why?
|